Met Life Investment Management, LLC Absci Corp Transaction History
Met Life Investment Management, LLC
- $16.5 Billion
- Q2 2025
A detailed history of Met Life Investment Management, LLC transactions in Absci Corp stock. As of the latest transaction made, Met Life Investment Management, LLC holds 68,700 shares of ABSI stock, worth $204,039. This represents 0.0% of its overall portfolio holdings.
Number of Shares
68,700
Previous 33,106
107.52%
Holding current value
$204,039
Previous $83,000
112.05%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding ABSI
# of Institutions
144Shares Held
69MCall Options Held
361KPut Options Held
542K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl10MShares$29.8 Million0.21% of portfolio
-
Redmile Group, LLC San Francisco, CA8.25MShares$24.5 Million2.18% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.45MShares$19.2 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.34MShares$15.9 Million0.0% of portfolio
-
Fred Alger Management, LLC New York, NY4.29MShares$12.8 Million0.07% of portfolio
About Absci Corp
- Ticker ABSI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 92,843,504
- Market Cap $276M
- Description
- Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process....